iPSCs derived cell therapy (Orig3n)

N/A

Report date: 2025/01/26 15:39:33

Base Information

Drug NameiPSCs derived cell therapy (Orig3n)
Drug Alias Nameinduced pluripotent stem-cell (iPSC) derived cell therapy (Orig3n)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesORIG3N Inc
China Registration ClassN/A

Develop Information

Active CompaniesORIG3N Inc
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A